secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001104659-25-085977
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics presents at Citi Biopharma Conference; no specific updates disclosed in filing excerpt
--------------------------------------------------------------------------------

- Company presented at Citi's 2025 Biopharma Back to School Conference on September 2, 2025.
- Presentation titled 'Leveraging Genetics to Treat Neurological Diseases' focuses on genetic approaches.
- No financial results, pipeline milestones, or guidance changes are identifiable from the provided excerpt.
- The filing does not contain material new information beyond the fact of the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465925085977/0001104659-25-085977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465925085977/tm2524800d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-085977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer